The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease

被引:21
作者
Wang Dong-xue [1 ,2 ]
Liu Hong [1 ,2 ]
Yan Li-rong [1 ,2 ]
Zhang Ye-ping [1 ,2 ]
Guan Xiao-yuan [1 ,2 ]
Xu Zhi-min [1 ,2 ]
Jia You-hong [1 ,2 ]
Li Yi-shi [1 ,2 ]
机构
[1] Peking Union Med Coll, Key Lab Clin Trial Res Cardiovasc Drugs, State Key Lab Cardiovasc Dis, Minist Hlth,Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China
[2] Chinese Acad Med Sci, Beijing 100037, Peoples R China
关键词
coronary heart disease; lipoproteins; high-density lipoprotein; serum amyloid A protein; apolipoprotein A-I; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; LDL OXIDATION; CHOLESTEROL; HDL; PROTEIN; RISK; SIZE; SAA; ATHEROSCLEROSIS;
D O I
10.3760/cma.j.issn.0366-6999.20130400
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Alteration in the protein composition of high-density lipoprotein (HDL) has been proposed as a mechanism for the development of coronary heart disease (CHD). In HDL, an increase in serum amyloid A protein (SAA) accompanying the decrease in apolipoprotein A-I (apoA-I) has been found during the acute inflammation period. However, whether this phenomenon persists in CHD patients, a disease related to inflammation, is unknown. The purpose of the present study was to explore the relationship between SAA and apoA-I in HDL isolated from CHD patients. Methods Overall, 98 patients with confirmed stable CHD and 90 control subjects matched for age and gender were enrolled in this case-control study. Potassium bromide (KBr) density gradient ultracentrifugation was used to isolate HDL from plasma. The levels of SAA and apoA-I in the HDL samples were detected by enzyme-linked immunosorbent assay kits. Pearson's correlation and general linear models were used in the analysis. Results Compared with controls, patients with CHD had a significant decrease in the amount of apoA-I ((14.21+/-8.44) mu g/ml vs. (10.95+/-5.95) mu g/ml, P =0.003) in HDL and a significant increase in the amount of log SAA (1.21+/-0.46 vs. 1.51+/-0.55, P <0.00001). Differences were independent of age, body mass index (BMI), HDL cholesterol (HDL-C), and other factors. An independently and statistically significant positive correlation between log SAA and apoA-I in HDL was observed only in the CHD group (beta =2.0, P =0.026). In the general linear model, changes in log(SAA), age, age(2), gender, BMI and HDL-C could explain a statistically significant 43% of the variance in apoA-I. Conclusions This study provides direct evidence for the first time that there was an independent positive correlation between log SAA and apoA-I in the HDL of CHD patients, indicating the alteration of protein composition in HDL. However, the question of whether this alteration in HDL is associated with impairment of HDL functions requires further research.
引用
收藏
页码:3656 / 3661
页数:6
相关论文
共 33 条
[1]   Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women [J].
Abbas, A ;
Fadel, PJ ;
Wang, ZY ;
Arbique, D ;
Jialal, I ;
Vongpatanasin, WP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (10) :E164-E167
[2]   The HDL proteome in acute coronary syndromes shifts to an inflammatory profile [J].
Alwaili, Khalid ;
Bailey, Dana ;
Awan, Zuhier ;
Bailey, Swneke D. ;
Ruel, Isabelle ;
Hafiane, Anouar ;
Krimbou, Larbi ;
Laboissiere, Sylvie ;
Genest, Jacques .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2012, 1821 (03) :405-415
[3]   The two faces of the 'good' cholesterol [J].
Ansell, Benjamin J. .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2007, 74 (10) :697-+
[4]  
Ansell BJ, 2007, CLEV CLIN J MED, V74(, P703
[5]   SERUM AMYLOID-A IS A CHEMOATTRACTANT - INDUCTION OF MIGRATION, ADHESION, AND TISSUE INFILTRATION OF MONOCYTES AND POLYMORPHONUCLEAR LEUKOCYTES [J].
BADOLATO, R ;
WANG, JM ;
MURPHY, WJ ;
LLOYD, AR ;
MICHIEL, DF ;
BAUSSERMAN, LL ;
KELVIN, DJ ;
OPPENHEIM, JJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :203-209
[6]  
BANKA CL, 1995, J LIPID RES, V36, P1058
[7]   Effects of torcetrapib in patients at high risk for coronary events [J].
Barter, Philip J. ;
Caulfield, Mark ;
Eriksson, Mats ;
Grundy, Scott M. ;
Kastelein, John J. P. ;
Komajda, Michel ;
Lopez-Sendon, Jose ;
Mosca, Lori ;
Tardif, Jean-Claude ;
Waters, David D. ;
Shear, Charles L. ;
Revkin, James H. ;
Buhr, Kevin A. ;
Fisher, Marian R. ;
Tall, Alan R. ;
Brewer, Bryan .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) :2109-2122
[8]   High-density lipoproteins: A new potential therapeutic target for the prevention of cardiovascular disease [J].
Brewer, HB .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (03) :387-391
[9]   INCIDENCE OF CORONARY HEART-DISEASE AND LIPOPROTEIN CHOLESTEROL LEVELS - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP ;
GARRISON, RJ ;
WILSON, PWF ;
ABBOTT, RD ;
KALOUSDIAN, S ;
KANNEL, WB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2835-2838
[10]   High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease [J].
Chen Guo-liang ;
Liu Li-wei ;
Xie Shuang ;
Liu Hong ;
Liu Yu-qing ;
Li Yi-shi .
CHINESE MEDICAL JOURNAL, 2010, 123 (06) :658-663